Perceptions of Obesity Among Healthcare Professionals and Policy Makers in 2023: Results of the Global OPEN Survey
Obesity Science & Practice,
Год журнала:
2025,
Номер
11(1)
Опубликована: Янв. 8, 2025
ABSTRACT
Objective
Obesity
is
a
disease
with
severe
health
impacts
on
individuals
and
economic
society,
yet
healthcare
practitioners
(HCPs)
policy
makers
often
fail
to
address
it.
This
survey
was
conducted
examine
current
global
obesity
care
perceptions
influencing
delivery
among
HCPs
decision
(HC
DMs).
Methods
A
cross‐sectional
design
1200
(primary
providers,
endocrinologists,
cardiologists,
nurses)
414
HC
DMs
from
eight
countries
across
five
continents.
Respondents'
of
obesity,
characteristics
patient
populations,
management
practices,
obesity‐related
policies
were
collected.
Surveys
administered
online
June–July
2023.
All
respondent
data
anonymized.
Results
Among
HCPs,
26.4%
29.0%
considered
chronic
disease,
44.6%
reported
that
recorded
as
in
patients'
medical
records.
The
pattern
responses
consistent
professional
roles.
approaches
focused
lifestyle
concerns.
appeared
overestimate
the
provision
for
affected
patients.
Conclusion
These
results
corroborate
prior
findings
many
do
not
consider
which
hinders
initiation
appropriate
treatment,
also
highlight
challenges
management,
including
gaps
guidelines
accessibility
healthcare.
may
help
guide
education
outreach
by
authorities
well
HCPs.
Язык: Английский
Trends in Obesity Care Among US Adults, 2010–2021
Medical Care,
Год журнала:
2025,
Номер
unknown
Опубликована: Янв. 10, 2025
Obesity
is
a
major
contributor
to
mortality
in
the
United
States.
Clinical
guidelines
emphasize
need
for
multimodal
treatment,
but
novel
treatments
may
be
changing
care-seeking
behavior.
To
characterize
obesity
treatment
access
patterns
and
factors
associated
with
care
from
2010
2021
This
multiyear
cross-sectional
study
was
conducted
using
Medical
Expenditure
Panel
Survey
(MEPS)
data,
covering
respondents
2021.
We
defined
individuals
BMI
≥30
or
those
any
health
event
linked
diagnosis
of
as
being
clinically
eligible
treatment.
The
primary
outcome
proportion
assumed
who
accessed
were
prescribed
medication
treat
each
calendar
year
population
82,729.
In
total,
1311
(1.6%)
reported
receiving
obesity.
participants
prescription
increased
0.3%
(0.2%,
0.6%)
1.8%
(1.3%,
2.5%)
Multivariable
logistic
regression
found
that
female
individuals,
older
higher
levels
education
had
odds
accessing
Utilization
pharmaceutical
nonpharmaceutical
has
remains
low.
likelihood
lower
groups
socioeconomic
status.
As
more
effective
therapies
become
available,
efforts
should
made
ensure
equitable
access.
Язык: Английский
Development of the International Federation for Surgery of Obesity and Metabolic Disorders-European Chapter (IFSO-EC) Grade-Based Guidelines on the Surgical Treatment of Obesity Using Multimodal Strategies: Design and Methodological Aspects
Journal of Clinical Medicine,
Год журнала:
2024,
Номер
13(17), С. 5106 - 5106
Опубликована: Авг. 28, 2024
Background:
The
prevalence
of
obesity
is
already
a
worldwide
health
concern.
development
straightforward
guidelines
regarding
the
whole
available
armamentarium
(i.e.,
medical,
endoscopic,
and
surgical
interventions
in
conjunction
with
guidance
program)
paramount
to
offering
best
multimodal
approach
patients
obesity.
Methods:
International
Federation
for
Surgery
Obesity
Metabolic
Disorders-European
Chapter
(IFSO-EC)
identified
panel
experts
develop
present
guidelines.
formulated
series
clinical
questions
(based
on
patient,
intervention,
comparison,
outcome
conceptual
framework),
which
have
been
voted
approved.
A
GRADE
methodology
will
be
applied
assess
quality
evidence
formulate
recommendations
employed
minimize
selection
information
biases.
This
aims
enhance
reliability
validity
recommendations,
promoting
greater
adherence
evidence.
Results:
These
are
intended
adult
body
mass
index
(BMI)
≥
30
kg/m2
who
candidates
metabolic
bariatric
surgery
(MBS).
expert
responsible
developing
these
comprised
25
panelists
(92%
were
surgeons)
3
reviewers,
an
average
age
50.1
±
10.2
years.
focused
key
combined
use
structured
lifestyle
interventions,
approved
management
medications,
endoscopic
weight
loss
procedures
MBS.
Conclusions:
complexity
as
chronic
disease
requires
comprehensive
knowledge
all
feasible
therapeutic
options.
IFSO-EC
society
felt
urgent
need
methodologically
valid
give
full
picture
awareness
possible
non-surgical
strategies
approach.
Язык: Английский
Rare Complications Following Laparoscopic Sleeve Gastrectomy
Journal of Clinical Medicine,
Год журнала:
2024,
Номер
13(15), С. 4456 - 4456
Опубликована: Июль 30, 2024
Metabolic
and
bariatric
surgery
(MBS)
is
the
most
effective
durable
therapeutic
intervention
for
patients
with
obesity.
In
recent
years,
laparoscopic
sleeve
gastrectomy
(SG)
has
become
commonly
performed
primary
MBS
procedure
owing
to
its
technical
feasibility
excellent
short-term
outcomes.
Despite
these
favorable
results
perceived
advantages,
SG
associated
several
unique
complications.
Complications
such
as
a
postoperative
leak
or
bleeding
have
been
more
observed
reported
than
others,
their
management
approaches
are
well
described.
However,
other
complications
following
far
less
familiar
surgeons,
which
may
delay
recognition
result
in
poor
patient
Of
complications,
we
describe
splenic
injuries;
esophageal
perforation;
staple
line
malformations;
stapling
of
intraluminal
devices;
phytobezoar
formation;
gastro-colic,
gastro-pleural
gastro-bronchial
fistula;
pancreatic
leak;
portomesenteric
venous
thrombosis.
It
paramount
surgeons
be
aware
underreported
issues
resources
learn
how
recognize
manage
them
when
they
arise.
This
review
aims
rare
(i.e.,
incidence
<1%)
underdescribed
after
SG,
focusing
on
causes,
clinical
presentation,
prevention
strategies,
management.
Язык: Английский